PortfoliosLab logoPortfoliosLab logo
Health
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


GILD 14.00%PODD 14.00%DGX 13.06%BSX 11.67%MCK 11.20%JNJ 10.36%INCY 7.50%CAH 6.34%52 positions 11.87%EquityEquity
PositionCategory/SectorTarget Weight
A
Agilent Technologies, Inc.
Healthcare
0%
ABBV
AbbVie Inc.
Healthcare
2.63%
ABT
Abbott Laboratories
Healthcare
0%
ALGN
Align Technology, Inc.
Healthcare
0%
AMGN
Amgen Inc.
Healthcare
0%
BAX
Baxter International Inc.
Healthcare
0%
BDX
Becton, Dickinson and Company
Healthcare
0%
BIIB
Biogen Inc.
Healthcare
0%
BMY
Bristol-Myers Squibb Company
Healthcare
0%
BSX
Boston Scientific Corporation
Healthcare
11.67%
CAH
Cardinal Health, Inc.
Healthcare
6.34%
CI
Cigna Corporation
Healthcare
0%
CNC
Centene Corporation
Healthcare
0%
COO
The Cooper Companies, Inc.
Healthcare
0%
COR
Cencora Inc.
Healthcare
4.76%
CRL
Charles River Laboratories International, Inc.
Healthcare
0%
CVS
CVS Health Corporation
Healthcare
0%
DGX
Quest Diagnostics Incorporated
Healthcare
13.06%
DHR
Danaher Corporation
Healthcare
0%
DVA
DaVita Inc.
Healthcare
0%
DXCM
DexCom, Inc.
Healthcare
0%
ELV
Elevance Health Inc
Healthcare
0%
EW
Edwards Lifesciences Corporation
Healthcare
0%
GEHC
GE HealthCare Technologies Inc.
Healthcare
0%
GILD
Gilead Sciences, Inc.
Healthcare
14%
HCA
HCA Healthcare, Inc.
Healthcare
0.84%
HOLX
Hologic, Inc.
Healthcare
0%
HSIC
Henry Schein, Inc.
Healthcare
0%
HUM
Humana Inc.
Healthcare
0%
IDXX
IDEXX Laboratories, Inc.
Healthcare
0%
INCY
Incyte Corporation
Healthcare
7.50%
IQV
IQVIA Holdings Inc.
Healthcare
0%
ISRG
Intuitive Surgical, Inc.
Healthcare
0%
JNJ
Johnson & Johnson
Healthcare
10.36%
LH
Laboratory Corporation of America Holdings
Healthcare
0%
LLY
Eli Lilly and Company
Healthcare
0%
MCK
McKesson Corporation
Healthcare
11.20%
MDT
Medtronic plc
Healthcare
0%
MOH
Molina Healthcare, Inc.
Healthcare
0%
MRK
Merck & Co., Inc.
Healthcare
0%
MRNA
Moderna, Inc.
Healthcare
0%
MTD
Mettler-Toledo International Inc.
Healthcare
0%
PFE
Pfizer Inc.
Healthcare
0%
PODD
Insulet Corporation
Healthcare
14%
REGN
Regeneron Pharmaceuticals, Inc.
Healthcare
0%
RMD
ResMed Inc.
Healthcare
3.64%
RVTY
Revvity Inc.
Healthcare
0%
SOLV
Solventum Corp
Healthcare
0%
STE
STERIS plc
Healthcare
0%
SYK
Stryker Corporation
Healthcare
0%
TECH
Bio-Techne Corporation
Healthcare
0%
TMO
Thermo Fisher Scientific Inc.
Healthcare
0%
UHS
Universal Health Services, Inc.
Healthcare
0%
UNH
UnitedHealth Group Incorporated
Healthcare
0%
VRTX
Vertex Pharmaceuticals Incorporated
Healthcare
0%
VTRS
Viatris Inc.
Healthcare
0%
WAT
Waters Corporation
Healthcare
0%
WST
West Pharmaceutical Services, Inc.
Healthcare
0%
ZBH
Zimmer Biomet Holdings, Inc.
Healthcare
0%
ZTS
Zoetis Inc.
Healthcare
0%

S&P 500 Index

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Health, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.


Loading graphics...

The earliest data available for this chart is Mar 26, 2024, corresponding to the inception date of SOLV

Returns By Period


1D1MYTD6M1Y3Y*5Y*10Y*
Benchmark
S&P 500 Index
0.11%-3.43%-3.84%-1.98%16.08%16.86%10.37%12.29%
Portfolio
Health
0.28%-8.20%-1.87%3.03%15.92%
LLY
Eli Lilly and Company
-1.98%-7.16%-12.80%14.47%15.19%39.72%39.64%31.19%
JNJ
Johnson & Johnson
-0.44%-1.50%18.06%32.21%60.80%19.22%11.44%11.41%
ABBV
AbbVie Inc.
-2.86%-10.70%-7.86%-10.37%5.19%13.21%18.43%18.22%
UNH
UnitedHealth Group Incorporated
1.20%-3.39%-15.36%-20.48%-45.51%-15.89%-3.82%9.69%
ABT
Abbott Laboratories
0.48%-9.45%-17.48%-21.91%-20.56%2.41%-1.07%11.35%
MRK
Merck & Co., Inc.
0.02%1.62%15.68%37.20%44.64%6.77%13.97%12.22%
TMO
Thermo Fisher Scientific Inc.
-0.62%-3.18%-15.10%-6.22%0.86%-4.53%1.77%13.38%
AMGN
Amgen Inc.
-1.51%-7.71%7.04%18.64%17.39%16.07%10.31%11.72%
ISRG
Intuitive Surgical, Inc.
-2.67%-9.12%-20.18%2.05%-10.84%21.26%12.65%20.66%
PFE
Pfizer Inc.
-0.81%6.55%15.64%8.20%22.98%-6.37%0.03%4.18%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Mar 27, 2024, Health's average daily return is +0.09%, while the average monthly return is +1.85%. At this rate, your investment would double in approximately 3.2 years.

Historically, 77% of months were positive and 23% were negative. The best month was Nov 2024 with a return of +8.0%, while the worst month was Mar 2026 at -9.5%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 1 months.

On a daily basis, Health closed higher 55% of trading days. The best single day was Apr 9, 2025 with a return of +3.6%, while the worst single day was Apr 4, 2025 at -4.9%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20263.79%4.17%-9.51%0.29%-1.87%
20257.33%5.36%-1.06%0.56%5.33%1.70%-1.60%5.77%1.07%3.59%6.94%-5.83%32.25%
20241.59%-2.46%2.43%3.22%4.37%4.96%1.32%1.69%7.99%-4.78%21.58%

Benchmark Metrics

Health has an annualized alpha of 20.56%, beta of 0.39, and R² of 0.19 versus S&P 500 Index. Calculated based on daily prices since March 27, 2024.

  • This portfolio captured 134.83% of S&P 500 Index gains but only 62.12% of its losses — a favorable profile for investors.
  • Beta of 0.39 may look defensive, but with R² of 0.19 this portfolio is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this portfolio's risk.
  • R² of 0.19 means this portfolio moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
20.56%
Beta
0.39
0.19
Upside Capture
134.83%
Downside Capture
62.12%

Expense Ratio

Health has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


The portfolio doesn't include any funds that charge management fees.

Return for Risk

Risk / Return Rank

Health ranks 26 for risk / return — below 26% of portfolios on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


Health Risk / Return Rank: 2626
Overall Rank
Health Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
Health Sortino Ratio Rank: 2828
Sortino Ratio Rank
Health Omega Ratio Rank: 2020
Omega Ratio Rank
Health Calmar Ratio Rank: 3030
Calmar Ratio Rank
Health Martin Ratio Rank: 2222
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics


PortfolioBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.99

0.88

+0.11

Sortino ratio

Return per unit of downside risk

1.46

1.37

+0.09

Omega ratio

Gain probability vs. loss probability

1.18

1.21

-0.02

Calmar ratio

Return relative to maximum drawdown

1.61

1.39

+0.22

Martin ratio

Return relative to average drawdown

5.00

6.43

-1.44


How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

Risk / Return RankSharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
LLY
Eli Lilly and Company
510.360.781.110.561.37
JNJ
Johnson & Johnson
973.514.771.647.4825.03
ABBV
AbbVie Inc.
430.190.441.060.280.62
UNH
UnitedHealth Group Incorporated
11-0.89-1.090.82-0.76-1.00
ABT
Abbott Laboratories
7-0.89-1.080.85-0.81-2.01
MRK
Merck & Co., Inc.
821.552.201.282.897.69
TMO
Thermo Fisher Scientific Inc.
380.030.291.030.080.17
AMGN
Amgen Inc.
590.601.071.131.102.65
ISRG
Intuitive Surgical, Inc.
25-0.32-0.280.97-0.37-0.69
PFE
Pfizer Inc.
680.871.381.171.894.26

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Health Sharpe ratios as of Apr 2, 2026 (values are recalculated daily):

  • 1-Year: 0.99
  • All Time: 1.77

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 1.00 to 1.69, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of Health compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading graphics...

Dividends

Dividend yield

Health provided a 1.01% dividend yield over the last twelve months.


TTM20252024202320222021202020192018201720162015
Portfolio1.01%1.11%1.38%1.47%1.36%1.68%1.96%1.97%1.77%1.37%1.36%1.14%
LLY
Eli Lilly and Company
0.67%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%
JNJ
Johnson & Johnson
2.14%2.48%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%
ABBV
AbbVie Inc.
3.18%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
UNH
UnitedHealth Group Incorporated
3.19%2.64%1.62%1.38%1.21%1.12%1.38%1.41%1.38%1.30%1.48%1.59%
ABT
Abbott Laboratories
2.33%1.88%1.95%1.85%1.71%1.28%1.32%1.47%1.55%1.86%2.71%2.14%
MRK
Merck & Co., Inc.
2.75%3.12%3.14%2.72%2.52%3.41%3.03%2.48%2.60%3.36%3.14%3.43%
TMO
Thermo Fisher Scientific Inc.
0.36%0.30%0.30%0.26%0.22%0.16%0.19%0.23%0.30%0.32%0.43%0.42%
AMGN
Amgen Inc.
2.78%2.91%3.45%2.96%2.95%3.13%2.78%2.41%2.71%2.65%2.74%1.95%
ISRG
Intuitive Surgical, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PFE
Pfizer Inc.
6.07%6.91%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.53%3.69%3.47%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Health. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Health was 10.53%, occurring on Mar 30, 2026. The portfolio has not yet recovered.

The current Health drawdown is 9.50%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-10.53%Mar 2, 202621Mar 30, 2026
-8.54%Mar 4, 202526Apr 8, 202523May 12, 202549
-7.72%Nov 26, 20259Dec 9, 202543Feb 11, 202652
-6.56%Nov 12, 202426Dec 18, 202424Jan 27, 202550
-5.6%Apr 1, 202414Apr 18, 202419May 15, 202433

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Diversification

Diversification Metrics


Number of Effective Assets

The portfolio contains 60 assets, with an effective number of assets of 9.33, reflecting the diversification based on asset allocation. This number of effective assets indicates a moderate level of diversification, where some assets may have a more significant influence on overall performance.

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

The correlation results are calculated based on daily price changes starting from Mar 27, 2024